Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study
Publication date
2025-12
Authors
Gootzen, Tamar A
Steenbeek, Miranda P
van Gelder, Marleen M H J
van Bommel, Majke H D
Timmer-Bonte, Anja J N H
Kets, C Marleen
Nitecki-Wilke, Roni
Swisher, Elizabeth M
Norquist, Barbara M
Lu, Karen H
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
BACKGROUND: Female BRCA1/2 pathogenic variant carriers have an increased risk of breast and ovarian cancer. In the TUBA-WISP II study, women chose between standard risk-reducing salpingo-oophorectomy and risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer. At inclusion, a substantial proportion of the enrolled women had a history of breast cancer, which could affect decision-making. OBJECTIVE: This study aimed to describe decision-making regarding the type and timing of risk-reducing surgery between women with and without a history of breast cancer. STUDY DESIGN: Premenopausal BRCA1/2 pathogenic variant carriers completed Web-based questionnaires on their personal histories and preferred risk-reducing strategy. Differences in the type and timing of the first risk-reducing surgery between women with and without a history of breast cancer were assessed. A multivariate analysis was performed to examine personal, environmental, and breast cancer-related characteristics associated with the choice of risk-reducing salpingo-oophorectomy among women with a history of breast cancer. RESULTS: This study included 1676 women, among whom 222 (13.2%) had a history of breast cancer. Of note, 77.0% of women with a history of breast cancer chose risk-reducing salpingectomy with delayed oophorectomy compared with 78.0% of women without a history of breast cancer (P=.73). Individuals with breast cancer before their BRCA1/2 diagnosis had their first surgery at a median of 2 years later than those who were diagnosed simultaneously or had their BRCA1/2 diagnosis first. Women diagnosed with breast cancer within the guideline age range for completing risk-reducing salpingo-oophorectomy (35-40 years for BRCA1 and 40-45 years for BRCA2) more often chose risk-reducing salpingo-oophorectomy than those before the guideline age range (odds ratio, 6.2 [95% confidence interval, 1.9-19.9]). CONCLUSION: A history of breast cancer was not associated with a preference for a specific risk-reducing strategy. Women diagnosed with breast cancer within the guideline age range more often chose risk-reducing salpingo-oophorectomy than those diagnosed with breast cancer before the guideline age range.
Keywords
Adult, BRCA1 Protein/genetics, BRCA2 Protein/genetics, Breast Neoplasms/genetics, Decision Making, Female, Genes, BRCA1, Genes, BRCA2, Humans, Middle Aged, Ovarian Neoplasms/prevention & control, Ovariectomy, Prophylactic Surgical Procedures, Risk Reduction Behavior, Salpingectomy, Salpingo-oophorectomy, Surveys and Questionnaires, Journal Article
Citation
Gootzen, T A, Steenbeek, M P, van Gelder, M M H J, van Bommel, M H D, Timmer-Bonte, A J N H, Kets, C M, Nitecki-Wilke, R, Swisher, E M, Norquist, B M, Lu, K H, Hermens, R P M G, de Hullu, J A & TUBA-WISP II Consortium 2025, 'Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study', American Journal of Obstetrics and Gynecology, vol. 233, no. 6, pp. 638.e1-638.e13. https://doi.org/10.1016/j.ajog.2025.06.024